Anti-IL23α Antibody

●Purchase●DescriptionThispurifiedrecombinantmonoclonalantibodyisahumananti-IL23αthatselectivelybindstothep19subunitofheterodimericIL-23,whichiscomposedofp19andIL-12p40

产品型号：101453

更新时间：2024-11-25

在线询价联系我们

详细介绍

品牌	BPS Bioscience

●

Purchase

●

Description

This purified recombinant monoclonal antibody is a human anti-IL23α that selectively binds to the p19 subunit of heterodimeric IL-23, which is composed of p19 and IL-12 p40. The variable regions for this antibody are based on an FDA-approved drug Skyrizi® (risankizumab-rzaa), sold by AbbVie. This antibody has been tested for specific binding affinity to IL23α/IL12β antigen.

●

Synonyms

Risankizumab, Interleukin-23 subunit alpha, IL-23 subunit alpha; IL-23-A, Interleukin-23 subunit p19 (IL-23p19), IL23A, SGRF, UNQ2498/PRO5798

●

Product Data Gallery